AbbVie Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. (ABBV) slipped 0.33% to $148.71 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.76% to 3,898.85 and Dow Jones Industrial Average falling 0.76% to 33,044.56. This was the stock's third consecutive day of losses. AbbVie Inc. closed $27.20 short of its 52-week high ($175.91), which the company reached on April 8th.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) fell 0.14% to $169.53 and Pfizer Inc. (PFE) fell 0.09% to $44.96. Trading volume (7.2 M) eclipsed its 50-day average volume of 5.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 19, 2023.
(END) Dow Jones Newswires
January 19, 2023 16:33 ET (21:33 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.